Targeted Gynaecologic Oncology (TARGON)

University of Groningen > Faculty of Medical Sciences > Cancer Research Center Groningen (CRCG) > Targeted Gynaecologic Oncology (TARGON)

  1. 2017
  2. Milne, R. L., Kuchenbaecker, K. B., Michailidou, K., Beesley, J., Kar, S., Lindstrom, S., ... NBSC Collaborators (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics, 49(12), 1767-1778. DOI: 10.1038/ng.3785
  3. Deans, Z. C., Williams, H., Dequeker, E. M. C., Keppens, C., Normanno, N., Schuuring, E., ... IQN Path ASBL (2017). Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: A perspective from an EQA providers' survey. Virchows Archiv, 471(6), 809-813. DOI: 10.1007/s00428-017-2222-z
  4. Rozenberg, S., Maas, A., Mourits, M. J., Antoine, C., & Rees, M. (2017). Health and wellbeing after cancer. Maturitas, 105, 1-3. DOI: 10.1016/j.maturitas.2017.08.012
  5. Cebula, M., Riehn, M., Hillebrand, U., Kratzer, R. F., Kreppel, F., Koutsoumpli, G., ... Wirth, D. (2017). TLR9-Mediated Conditioning of Liver Environment Is Essential for Successful Intrahepatic Immunotherapy and Effective Memory Recall. Molecular Therapy, 25(10), 2289-2298. DOI: 10.1016/j.ymthe.2017.06.018
  6. Vermeulen, R. F. M., van Beurden, M., Kieffer, J. M., Bleiker, E. M. A., Valdimarsdottir, H. B., Massuger, L. F. A. G., ... Aaronson, N. K. (2017). Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study. European Journal of Cancer, 84, 159-167. DOI: 10.1016/j.ejca.2017.07.018
  7. Querleu, D., Planchamp, F., Chiva, L., Fotopoulou, C., Barton, D., Cibula, D., ... duBois, A. (2017). European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery. International Journal of Gynecological Cancer, 27(7), 1534-1542. DOI: 10.1097/IGC.0000000000001041
  8. Edmondson, R. J., Crosbie, E. J., Nickkho-Amiry, M., Kaufmann, A., Stelloo, E., Nijman, H. W., ... Kitchener, H. C. (2017). Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative. Gynecologic Oncology, 146(2), 327-333. DOI: 10.1016/j.ygyno.2017.05.014
  9. Verlaat, W., Snijders, P. J. F., Novianti, P. W., Wilting, S. M., De Strooper, L. M. A., Trooskens, G., ... Steenbergen, R. D. M. (2017). Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer. Clinical Cancer Research, 23(14), 3813-3822. DOI: 10.1158/1078-0432.CCR-16-2641
  10. van Leeuwen, R. W. F., Jansman, F. G. A., Hunfeld, N. G., Peric, R., Reyners, A. K. L., Imholz, A. L. T., ... Mathijssen, R. H. J. (2017). Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options. Clinical Pharmacokinetics, 56(7), 683-688. DOI: 10.1007/s40262-016-0503-3
  11. Moghadasi, S., Grundeken, V., Janssen, L. A. M., Dijkstra, N. H., Rodríguez-Girondo, M., van Zelst-Stams, W. A. G., ... van Asperen, C. J. (2017). Performance of BRCA1/2 mutation prediction models in male breast cancer patients. Clinical Genetics. DOI: 10.1111/cge.13065
  12. Shimelis, H., Mesman, R. L. S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C., ... NBCS Collaborators (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799. DOI: 10.1158/0008-5472.CAN-16-2568
  13. Flanagan, J. M., Wilson, A., Koo, C., Masrour, N., Gallon, J., Loomis, E., ... Brown, R. (2017). Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer. Clinical Cancer Research, 23(9), 2213-2222. DOI: 10.1158/1078-0432.CCR-16-1754
Previous 1 2 3 4 5 6 7 8 ...31 Next

ID: 37379